A Study of Intratumoral CAVATAK™ in Patients With Stage IIIc and Stage IV Malignant Melanoma (VLA-007 CALM )
Public ClinicalTrials.gov record NCT01227551. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study of the Efficacy and Safety of Intratumoral CAVATAK™ (Coxsackievirus A21, CVA21) in Patients With Stage IIIc and Stage IV Malignant Melanoma (VLA-007 CALM )
Study identification
- NCT ID
- NCT01227551
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Viralytics
- Industry
- Enrollment
- 57 participants
Conditions and interventions
Conditions
Interventions
- Coxsackievirus A21 (CVA21) Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 28, 2011
- Primary completion
- Apr 5, 2016
- Completion
- Apr 5, 2016
- Last update posted
- Jul 4, 2019
2011 – 2016
United States locations
- U.S. sites
- 10
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Moores UCSD Cancer Center | La Jolla | California | 92093 | — |
| St Mary's Medical Center | San Francisco | California | 94117 | — |
| Mount Sinai Medical Center | Miami Beach | Florida | 33140 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Oncology Specialists, SC | Niles | Illinois | 60714 | — |
| Investigative Clinical Research of Indiana | Indianapolis | Indiana | 46260 | — |
| Atlantic Melanoma Center | Morristown | New Jersey | 07962 | — |
| Providence Cancer Center | Portland | Oregon | 97213 | — |
| Mary Crowley Cancer Research Centers | Dallas | Texas | 75201 | — |
| Huntsman Cancer Institute | Salt Lake City | Utah | 84112 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01227551, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 4, 2019 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01227551 live on ClinicalTrials.gov.